| Risk-free interest rate | 4.61 | % | ||
| Expected term (in years) | 5.92 | |||
| Expected volatility | 60 | % | ||
| Expected dividend yield | 0 | % | ||
| Grant date fair value | $ | 6.70 |
| Name and Principal Position | Year | Salary ($) | Bonus ($)(1) | Stock Awards ($) | Option Awards ($)(2) | Non-Equity Incentive Plan Compensation ($)(3) | All Other Compensation ($)(4) | Total ($) | ||||||||||||||||||||||
| Harith Rajagopalan, M.D., Ph.D. | 2023 | $ | 550,000 | $ | 2,430,014 | $ | 267,990 | $ | 313,500 | $ | 270 | $ | 3,561,774 | |||||||||||||||||
| Chief Executive Officer | 2022 | $ | 550,000 | — | $ | 78,602 | $ | 221,100 | $ | 280 | $ | 849,982 | ||||||||||||||||||
| Timothy Kieffer, Ph.D.(5) | 2023 | $ | 92,438 | $ | 25,000 | — | $ | 3,321,650 | $ | 23,200 | $ | 3,462,288 | ||||||||||||||||||
| Chief Scientific Officer | ||||||||||||||||||||||||||||||
| Jay D. Caplan | 2023 | $ | 400,000 | $ | 2,097,678 | $ | 220,507 | $ | 154,000 | $ | 1,188 | $ | 2,873,373 | |||||||||||||||||
| President and Chief Product Officer | ||||||||||||||||||||||||||||||
| Option Awards | |||||||||||||||||||||||||||
| Name | Vesting Start Date | Underlying Un-exercised Options (#) Exercisable | Underlying Un-exercised Options (#) Un-exercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock that have not Vested (#) | Market Value of Shares of Units of Stock that have not Vested ($)(1) | ||||||||||||||||||||
| Harith Rajagopalan, M.D., Ph.D.(2). | 8/19/2014 | 190,968 | 0 | 1.70 | 11/10/2024 | — | — | ||||||||||||||||||||
| 3/01/2015 | 123,484 | 0 | 1.70 | 2/09/2025 | — | — | |||||||||||||||||||||
| 12/17/2015 | 345,078 | — | $ | 2.67 | 12/16/2025 | — | — | ||||||||||||||||||||
| 6/27/2016 | 179,868 | 0 | 2.67 | 6/26/2026 | — | — | |||||||||||||||||||||
| 3/14/2018 | 422,473 | 0 | 3.35 | 3/13/2028 | — | — | |||||||||||||||||||||
| 3/26/2020 | 445,333 | 29,688 | 3.89 | 3/25/2030 | — | — | |||||||||||||||||||||
| 6/24/2021 | 164,335 | 98,602 | 6.98 | 6/23/2031 | — | — | |||||||||||||||||||||
| 9/07/2022 | 5,096 | 11,213 | 8.59 | 9/06/2032 | — | — | |||||||||||||||||||||
| 3/16/2023 | 6,116 | 26,502 | 8.18 | 3/15/2033 | — | — | |||||||||||||||||||||
| 11/10/2023 | 0 | 17,031 | (3) | 11.21 | 11/09/2033 | — | — | ||||||||||||||||||||
| $ | 325,386 | ||||||||||||||||||||||||||
| 11/10/2023 | — | — | — | 11/09/2030 | 216,924 | (7) | 0 | ||||||||||||||||||||
| Timothy Kieffer, Ph.D. | 10/14/2022 | 5,436 | (4) | 3,883 | 8.59 | 12/06/2032 | — | — | |||||||||||||||||||
| 9/12/2023 | 0 | 498,005 | (5) | 11.21 | 9/12/2033 | — | — | ||||||||||||||||||||
| Jay D. Caplan(6) | 8/19/2014 | 95,484 | 0 | 0.82 | 11/10/2024 | — | — | ||||||||||||||||||||
| 3/01/2015 | 61,742 | 0 | 1.70 | 2/09/2025 | — | — | |||||||||||||||||||||
| 12/17/2015 | 145,875 | — | $ | 2.67 | 12/16/2025 | — | — | ||||||||||||||||||||
| 6/27/2016 | 23,298 | 0 | 2.67 | 6/26/2026 | — | — | |||||||||||||||||||||
| 3/14/2018 | 94,879 | 0 | 3.35 | 3/13/2028 | — | — | |||||||||||||||||||||
| 3/26/2020 | 12,022 | 802 | 3.89 | 3/25/2030 | — | — | |||||||||||||||||||||
| 6/24/2021 | 24,358 | 14,616 | 6.98 | 6/23/2031 | — | — | |||||||||||||||||||||
| 9/07/2022 | 3,639 | 8,010 | 8.59 | 9/06/2032 | — | — | |||||||||||||||||||||
| 3/16/2023 | 4,805 | 20,823 | 8.18 | 3/15/2033 | — | — | |||||||||||||||||||||
| 11/10/2023 | 0 | 14,701 | (3) | 11.21 | 11/09/2033 | — | — | ||||||||||||||||||||
| 11/10/2023 | — | — | — | 11/09/2030 | 187,257 | (7) | $ | 2,808,855 | |||||||||||||||||||
| Incorporated by Reference | ||||||
| Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date | Filed/ Furnished Herewith |
| 10.4† | Fractyl Health, Inc. Amended and Restated 2011 Stock Incentive Plan and forms of award agreements thereunder. | S-1 | 333-276046 | 10.4 | 12/14/2023 | |
| 10.5† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Harith Rajagopalan, M.D., Ph.D. | S‑1/A | 333-276046 | 10.5 | 1/29/2024 | |
| 10.6† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Lisa A. Davidson. | S‑1/A | 333-276046 | 10.6 | 1/29/2024 | |
| 10.7† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Jay D. Caplan. | S‑1/A | 333-276046 | 10.7 | 1/29/2024 | |
| 10.8† | Employment Letter Agreement, dated January 26, 2024, by and between Fractyl Health, Inc. and Sarah Toomey. | S‑1/A | 333-276046 | 10.8 | 1/29/2024 | |
| 10.9† | Offer Letter, dated September 12, 2023, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.9 | 1/29/2024 | |
| 10.10† | First Amendment to Offer Letter, dated September 12, 2024, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.10 | 1/29/2024 | |
| 10.11† | Severance Agreement and Change in Control Agreement, dated September 12, 2023, by and between Fractyl Health, Inc. and Timothy Kieffer, Ph.D. | S‑1/A | 333-276046 | 10.11 | 1/29/2024 | |
| 10.12 † | First Amendment to Severance Agreement and Change in Control Agreement, by and between the Registrant and Timothy Kieffer, Ph.D. (to be in effect upon the effectiveness of this registration statement). | S-1/A | 333-276046 | 10.12 | 1/29/2024 | |
| 10.13 | Lease Agreement, dated August 10, 2022, by and between Fractyl Health, Inc. (f/k/a Fractyl Laboratories, Inc.) and BP 17 Hartwell LLC. | S-1 | 333-276046 | 10.11 | 12/14/2024 | |
| 10.14† | Fractyl Health, Inc. 2024 Incentive Award Plan and forms of award agreements thereunder. | * | ||||
| 10.15† | Fractyl Health, Inc. 2024 Employee Stock Purchase Plan. | S-1/A | 333-276046 | 10.16 | 1/29/2024 | |
| 10.16† | Fractyl Health, Inc. Non-Employee Director Compensation Program. | S-1/A | 333-276046 | 10.17 | 1/29/2024 | |
| 10.17† | Form of Indemnification Agreement by and among Fractyl Health, Inc. and its directors and officers. | S-1/A | 333-276046 | 10.18 | 12/14/2023 | |
| 21.1 | List of Subsidiaries | S‑1 | 333-276046 | 21.1 | 12/14/2023 | |
| 23.1 | Consent of Independent Registered Public Accounting Firm | * | ||||
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer | * | ||||
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer | * | ||||
| 32.1 | Section 1350 Certification of Chief Executive Officer | ** | ||||
| 32.2 | Section 1350 Certification of Chief Financial Officer | ** | ||||
| Option Awards | ||||||||||||||||||||||||||||
| Name | Vesting Start Date | Underlying Un-exercised Options (#) Exercisable | Underlying Un-exercised Options (#) Un-exercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock that have not Vested (#) | Market Value of Shares of Units of Stock that have not Vested ($)(1) | |||||||||||||||||||||
| Harith Rajagopalan, M.D., Ph.D.(2) . | 8/19/2014 | 190,968 | 0 | 1.70 | 11/10/2024 | — | — | |||||||||||||||||||||
| 3/01/2015 | 123,484 | 0 | 1.70 | 2/09/2025 | — | — | ||||||||||||||||||||||
| 12/17/2015 | 345,078 | — | $ | 2.67 | 12/16/2025 | — | — | |||||||||||||||||||||
| 6/27/2016 | 179,868 | 0 | 2.67 | 6/26/2026 | — | — | ||||||||||||||||||||||
| 3/14/2018 | 422,473 | 0 | 3.35 | 3/13/2028 | — | — | ||||||||||||||||||||||
| 3/26/2020 | 445,333 | 29,688 | 3.89 | 3/25/2030 | — | — | ||||||||||||||||||||||
| 6/24/2021 | 164,335 | 98,602 | 6.98 | 6/23/2031 | — | — | ||||||||||||||||||||||
| 9/07/2022 | 5,096 | 11,213 | 8.59 | 9/06/2032 | — | — | ||||||||||||||||||||||
| 3/16/2023 | 6,116 | 26,502 | 8.18 | 3/15/2033 | — | — | ||||||||||||||||||||||
| 11/10/2023 | 0 | 17,031 | (3) | 11.21 | 11/09/2033 | — | — | |||||||||||||||||||||
| $ | 3,253,86 | |||||||||||||||||||||||||||
| 11/10/2023 | — | — | — | 11/09/2030 | 216,924 | (7) | 0 | |||||||||||||||||||||
| Timothy Kieffer, Ph.D. | 10/14/2022 | 5,436 | (4) | 3,883 | 8.59 | 12/06/2032 | — | — | ||||||||||||||||||||
| 9/12/2023 | 0 | 498,005 | (5) | 11.21 | 9/12/2033 | — | — | |||||||||||||||||||||
| Jay D. Caplan(6) | 8/19/2014 | 95,484 | 0 | 0.82 | 11/10/2024 | — | — | |||||||||||||||||||||
| 3/01/2015 | 61,742 | 0 | 1.70 | 2/09/2025 | — | — | ||||||||||||||||||||||
| 12/17/2015 | 145,875 | — | $ | 2.67 | 12/16/2025 | — | — | |||||||||||||||||||||
| 6/27/2016 | 23,298 | 0 | 2.67 | 6/26/2026 | — | — | ||||||||||||||||||||||
| 3/14/2018 | 94,879 | 0 | 3.35 | 3/13/2028 | — | — | ||||||||||||||||||||||
| 3/26/2020 | 12,022 | 802 | 3.89 | 3/25/2030 | — | — | ||||||||||||||||||||||
| 6/24/2021 | 24,358 | 14,616 | 6.98 | 6/23/2031 | — | — | ||||||||||||||||||||||
| 9/07/2022 | 3,639 | 8,010 | 8.59 | 9/06/2032 | — | — | ||||||||||||||||||||||
| 3/16/2023 | 4,805 | 20,823 | 8.18 | 3/15/2033 | — | — | ||||||||||||||||||||||
| 11/10/2023 | 0 | 14,701 | (3) | 11.21 | 11/09/2033 | — | — | |||||||||||||||||||||
| 11/10/2023 | — | — | — | 11/09/2030 | 187,257 | (7) | $ | 2,808,855 | ||||||||||||||||||||
